Increased incidence rates of amyotrophic lateral sclerosis (ALS) have been recently reported across various Western countries, although geographic and temporal variations in terms of incidence, clinical features and genetics are not fully elucidated. This study aimed to describe demographic, clinical feature and genotype–phenotype correlations of ALS cases over the last decade in the Emilia Romagna Region (ERR). From 2009 to 2019, our prospective population-based registry of ALS in the ERR of Northern Italy recorded 1613 patients receiving a diagnosis of ALS. The age-and sex-adjusted incidence rate was 3.13/100,000 population (M/F ratio: 1.21). The mean age at onset was 67.01 years; women, bulbar and respiratory phenotypes were associated with an older age, while C9orf72-mutated patients were generally younger. After peaking at 70–75 years, incidence rates, among women only, showed a bimodal distribution with a second slight increase after reaching 90 years of age. Familial cases comprised 12%, of which one quarter could be attributed to an ALS-related mutation. More than 70% of C9orf72-expanded patients had a family history of ALS/fronto-temporal dementia (FTD); 22.58% of patients with FTD at diagnosis had C9orf72 expansion (OR 6.34, p = 0.004). In addition to a high ALS incidence suggesting exhaustiveness of case ascertainment, this study highlights interesting phenotype–genotype correlations in the ALS population of ERR.

Epidemiological, Clinical and Genetic Features of ALS in the Last Decade: A Prospective Population-Based Study in the Emilia Romagna Region of Italy / Gianferrari, G.; Martinelli, I.; Zucchi, E.; Simonini, C.; Fini, N.; Vinceti, M.; Ferro, S.; Gessani, A.; Canali, E.; Valzania, F.; Sette, E.; Pugliatti, M.; Tugnoli, V.; Zinno, L.; Stano, S.; Santangelo, M.; De Pasqua, S.; Terlizzi, E.; Guidetti, D.; Medici, D.; Salvi, F.; Liguori, R.; Vacchiano, V.; Casmiro, M.; Querzani, P.; Dossi, M. C.; Patuelli, A.; Morresi, S.; Longoni, M.; De Massis, P.; Rinaldi, R.; Borghi, A.; Amedei, A.; Mandrioli, J.. - In: BIOMEDICINES. - ISSN 2227-9059. - 10:4(2022), pp. 819-831. [10.3390/biomedicines10040819]

Epidemiological, Clinical and Genetic Features of ALS in the Last Decade: A Prospective Population-Based Study in the Emilia Romagna Region of Italy

Gianferrari G.;Martinelli I.;Zucchi E.;Simonini C.;Vinceti M.;Mandrioli J.
2022

Abstract

Increased incidence rates of amyotrophic lateral sclerosis (ALS) have been recently reported across various Western countries, although geographic and temporal variations in terms of incidence, clinical features and genetics are not fully elucidated. This study aimed to describe demographic, clinical feature and genotype–phenotype correlations of ALS cases over the last decade in the Emilia Romagna Region (ERR). From 2009 to 2019, our prospective population-based registry of ALS in the ERR of Northern Italy recorded 1613 patients receiving a diagnosis of ALS. The age-and sex-adjusted incidence rate was 3.13/100,000 population (M/F ratio: 1.21). The mean age at onset was 67.01 years; women, bulbar and respiratory phenotypes were associated with an older age, while C9orf72-mutated patients were generally younger. After peaking at 70–75 years, incidence rates, among women only, showed a bimodal distribution with a second slight increase after reaching 90 years of age. Familial cases comprised 12%, of which one quarter could be attributed to an ALS-related mutation. More than 70% of C9orf72-expanded patients had a family history of ALS/fronto-temporal dementia (FTD); 22.58% of patients with FTD at diagnosis had C9orf72 expansion (OR 6.34, p = 0.004). In addition to a high ALS incidence suggesting exhaustiveness of case ascertainment, this study highlights interesting phenotype–genotype correlations in the ALS population of ERR.
2022
10
4
819
831
Epidemiological, Clinical and Genetic Features of ALS in the Last Decade: A Prospective Population-Based Study in the Emilia Romagna Region of Italy / Gianferrari, G.; Martinelli, I.; Zucchi, E.; Simonini, C.; Fini, N.; Vinceti, M.; Ferro, S.; Gessani, A.; Canali, E.; Valzania, F.; Sette, E.; Pugliatti, M.; Tugnoli, V.; Zinno, L.; Stano, S.; Santangelo, M.; De Pasqua, S.; Terlizzi, E.; Guidetti, D.; Medici, D.; Salvi, F.; Liguori, R.; Vacchiano, V.; Casmiro, M.; Querzani, P.; Dossi, M. C.; Patuelli, A.; Morresi, S.; Longoni, M.; De Massis, P.; Rinaldi, R.; Borghi, A.; Amedei, A.; Mandrioli, J.. - In: BIOMEDICINES. - ISSN 2227-9059. - 10:4(2022), pp. 819-831. [10.3390/biomedicines10040819]
Gianferrari, G.; Martinelli, I.; Zucchi, E.; Simonini, C.; Fini, N.; Vinceti, M.; Ferro, S.; Gessani, A.; Canali, E.; Valzania, F.; Sette, E.; Pugliatti, M.; Tugnoli, V.; Zinno, L.; Stano, S.; Santangelo, M.; De Pasqua, S.; Terlizzi, E.; Guidetti, D.; Medici, D.; Salvi, F.; Liguori, R.; Vacchiano, V.; Casmiro, M.; Querzani, P.; Dossi, M. C.; Patuelli, A.; Morresi, S.; Longoni, M.; De Massis, P.; Rinaldi, R.; Borghi, A.; Amedei, A.; Mandrioli, J.
File in questo prodotto:
File Dimensione Formato  
biomedicines-10-00819.pdf

Open access

Tipologia: Versione pubblicata dall'editore
Dimensione 555.09 kB
Formato Adobe PDF
555.09 kB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

Licenza Creative Commons
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11380/1277129
Citazioni
  • ???jsp.display-item.citation.pmc??? 5
  • Scopus 9
  • ???jsp.display-item.citation.isi??? 8
social impact